On To the Point, Kristi Martin and Jeremy Sharp of Waxman Strategies tell the story of the Competitive Acquisition Program, which Congress established in 2003 — and shelved in 2008 — to test an alternative to physician negotiation of Part B drug prices. What lessons can be learned from that program? And does the administration's new proposal address the issues that arose in the first attempt?